GConferenceGridThe Conference Catalogue · Vol. 2026Folio № 57AA28
Of the Field

CPHI Middle East 2026

C

PHI Middle East 2026 returns to Riyadh after a record 2024 edition, promising more networking, direct market access, and insights on regulatory and pharmaceutical innovations. The event offers a comprehensive range of products and services spanning the entire pharma supply chain and brings together pharma professionals from over 110 countries for in-person…

Visit the official siteRegister
38Voices
3Underwriters
15Exhibitors
2On the bill · sessions
50Companies · in total
§I

The Voices

Programmed at CPHI, in alphabetical order.
Aaron Dely
VP of Research & Development · PLD Pharma Services
Alejandro Córdova Motte
Supply Chain & Access Director · CANIFARMA
Amanda Cowley
Global Quality Leader · GSK
Amit Limaye
Director · Becton Dickinson & Company (BD)
Anuji Abraham
Senior Director, Pharmaceutical Development · Altasciences
Bijoy Sagar
EVP & Chief Information & Digital Officer · Bayer
Brent Del Monte
Principal · BGR Group
Brian Beyer
Senior Manager · KPMG
Carrie Bracco
Head Business Development US - CMO · Novartis Contract Manufacturing
Chris Chen
Chief Executive Officer · WuXi Biologics
Claudia Roa
Global Sector President · DHA
Doaa Fathallah
Chief Operating Officer · Marken (UPS Healthcare)
Emily George
Account Executive, Customer Growth · EcoVadis
Giorgio Salciarini
Head of Sales- Technical Business Development · BSP Pharmaceuticals
Isis Valle
Regulatory Inteligence for Innovation · Franklin da Costa Attorneys & Consultants
Jeffrey Speicher
Commercial General Manager · PLD Pharma Services
John Lowry
Chairman and CEO · Praxis Packaging Solutions
John Nosta
Founder · NOSTALAB
Julia Sable
Director Technical Partnerships and Portfolio Management · Kite Pharmaceuticals
Karen Greene
Partner · Network Partners Group
Karen Kozarsky
President/CSO · Vector BioPartners
Kenneth Yancey
Senior Vice President, CMC · Franklin Biolabs

— and 16 more, by name unsung —

§II

Underwritten By

The houses behind the program. Tiers as disclosed.
IQVIAKnowledge Partner
Ministry of Health
Saudi Pharmaceutical SocietySupporting Association
§III

The Programme

Selected from 2 sessions on the bill.
  • June 3, 2026 (Day 2) 1:30 - 2:00pm

    John Nosta book signing

    Join us at CPHI Americas for a book signing with John Nosta, founder of NOSTALAB and author of The Borrowed Mind. A global innovation theorist and top tech influencer, John offers …

  • June 3, 2026 (Day 2), 1:30 - 2:00pm

    John Nosta book signing!

    Join us at CPHI Americas for a book signing with John Nosta, founder of NOSTALAB and author of The Borrowed Mind. A global innovation theorist and top tech influencer, John offers …

Intermission
Part the Second · For the Buyer

What does it mean when 50 companies show up — and 1 bet on three roles at once?

“50 companies. one are betting more than once.”

The numbers below are derived from the speakers, sponsors, and exhibitors on this page — cross-referenced into one ledger. They are the only thing here that 10times.com cannot tell you.

№ 01Fig. 01 — Composition of the House
1All threespeak · spons · exh
2Sponsoringsponsor only
15Exhibitingexhibitor only
32Speakingspeaker only

The Triple-Threat

IQVIA

№ 02Fig. 02 — The Voices, by Seniority

63% of the speakers carry senior titles — C-suite, Founder, VP, or Director-level.

  • C-suite924%
  • Founder / Owner38%
  • VP-level513%
  • Director / Head of718%
  • Manager / Lead411%
  • Research / Science13%
  • Advisor / Investor13%
  • Other roles821%

Of 38 on the bill · classified by free-text title

№ 03Fig. 03 — The Heaviest in the Room
  1. 01IQVIASp·K1V
  2. 02Ministry of HealthSp
  3. 03Saudi Pharmaceutical SocietySp·S
  4. 04AJA PharmaEx
  5. 05Altasciences2V
  6. 06AmaroxEx
  7. 07Avalon PharmaEx
  8. 08AxantiaEx
  9. 09BeaconEx
  10. 10Cooper PharmaEx
  11. 11GSK2V
  12. 12HeteroEx
  13. 13HikmaEx
  14. 14Network Partners Group2V
№ 04Fig. 04 — By Tier
knowledge partner1
33% of 3
supporting association1
33% of 3
unspecified1
33% of 3